Chiasma Inc (CHMA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select FieldsSymbol | CHMA | CRDF | PRQR | ||
Company | Chiasma Inc | Cardiff Oncology Inc | Proqr Therapeutics | ||
Price Information | |||||
Exchange | NASDAQ | NASDAQ | NASDAQ | ||
Open | 4.08 | 4.42 | 2.59 | ||
High | 4.10 | 4.67 | 2.70 | ||
Low | 3.76 | 4.20 | 2.47 | ||
Last | 3.76 | 4.26 | 2.63 | ||
Change | -0.24 | -0.23 | +0.04 | ||
% Change | -6.00% | -5.12% | +1.54% | ||
Volume | 8,196,700 | 2,099,000 | 718,700 | ||
20-Day Average Volume | 796,120 | 4,268,240 | 625,010 | ||
Previous Close | 4.00 | 4.49 | 2.59 | ||
Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
Has Options | No | Yes | Yes | ||
Technicals | |||||
20-Day Moving Average | 4.24 | 3.23 | 3.28 | ||
20-Day Raw Stochastic | 0.00% | 59.18% | 21.41% | ||
20-Day Relative Strength | 36.96% | 59.70% | 40.40% | ||
Weighted Alpha | -29.45 | +7.88 | -40.77 | ||
Today's Opinion | 24% Sell | 72% Buy | 24% Buy | ||
Previous Opinion | 24% Buy | 56% Buy | 24% Buy | ||
Last Month's Opinion | 72% Buy | 24% Sell | 96% Buy | ||
Performance | |||||
5-Days | |||||
%Chg | -9.40% since 07/29/21 | +8.67% since 12/13/24 | -7.07% since 12/13/24 | ||
Low | 3.76 on 08/05/21 | 3.76 on 12/16/24 | 2.27 on 12/16/24 | ||
High | 4.18 on 08/02/21 | 5.64 on 12/17/24 | 2.95 on 12/18/24 | ||
1-Month | |||||
%Chg | -20.17% since 07/02/21 | +68.38% since 11/20/24 | -28.34% since 11/20/24 | ||
Low | 3.76 on 08/05/21 | 2.26 on 12/06/24 | 2.27 on 12/16/24 | ||
High | 4.72 on 07/06/21 | 5.64 on 12/17/24 | 3.97 on 11/29/24 | ||
3-Month | |||||
%Chg | -5.53% since 05/05/21 | +58.96% since 09/20/24 | +52.02% since 09/20/24 | ||
Low | 3.70 on 05/06/21 | 2.26 on 12/06/24 | 1.65 on 09/24/24 | ||
High | 4.93 on 06/25/21 | 5.64 on 12/17/24 | 4.62 on 10/17/24 | ||
6-Month | |||||
%Chg | -13.66% since 02/05/21 | +74.59% since 06/20/24 | +53.80% since 06/20/24 | ||
Low | 2.77 on 03/29/21 | 2.01 on 08/05/24 | 1.61 on 07/03/24 | ||
High | 5.00 on 02/09/21 | 5.64 on 12/17/24 | 4.62 on 10/17/24 | ||
Key Statistics | |||||
Market Capitalization, $K | 217,681 | 217,831 | 214,818 | ||
Shares Outstanding, K | 57,894 | 51,134 | 81,680 | ||
Annual Sales | 1,110,000 | 490,000 | 7,050,000 | ||
Annual Net Income | -74,780,000 | -41,440,000 | -30,430,000 | ||
Last Quarter Sales | 1,920,000 | 170,000 | 4,230,000 | ||
Last Quarter Net Income | -30,550,000 | -11,860,000 | -8,920,000 | ||
60-Month Beta | 1.28 | 1.89 | 0.24 | ||
Per-Share Information | |||||
Most Recent Earnings | N/A | -0.25 on 11/07/24 | -0.11 on 11/07/24 | ||
Latest Earnings Date | 08/09/21 | 11/07/24 | 11/12/24 | ||
Most Recent Dividend | N/A | N/A | N/A | ||
Next Ex-Dividends Date | N/A | N/A | N/A | ||
Ratios | |||||
Price/Earnings ttm | 0.00 | 0.00 | 0.00 |